2 Results for "

PROTAC EGFR degrader15

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "PROTAC EGFR degrader15" in MCE Product Catalog:

Cat. No.: HY-175839
Target:  

PROTACs EGFR ATP Synthase

Research Areas:  

Inflammation/Immunology Cancer

PROTAC EGFR degrader 15 is a Pomalidomide (HY-10984)-based Gefitinib (HY-50895) EGFR PROTAC degrader. PROTAC EGFR degrader 15 triggers EGFR degradation via ubiquitin-proteasome-dependent proteolysis and autophagy-lysosome activation pathways. PROTAC EGFR degrader 15 targets ETFA to enhance ATP production. PROTAC EGFR degrader 15 significantly suppresses tumor growth in a Gefitinib-acquired resistant HCC-827 xenograft model. PROTAC EGFR degrader 15 can be used for the study of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-175887
CAS No.: 2545963-23-1
Research Areas:  

Cancer

Pomalidomide-C9-Br is a synthesized E3 ligase ligand-linker conjugate that can be used to synthesize PROTAC EGFR degrader 15 (HY-175839). PROTAC EGFR degrader 15 is a potent EGFR PROTAC degrader with anti-cancer activity .
loading...
    loading...